COMPANY
Amalgent Therapeutics
NIH awards 2
- NIH award 1R43DA059522-01 FY2024: $220,668 awarded for that fiscal year; activity R43 (SBIR); PI MEYN, MALCOLM A; recipient as written: AMALGENT THERAPEUTICS, INC., Greenville, NC. Mechanism and Efficacy of a Novel O source ↗
- NIH award 1R44DA059302-01 FY2023: $2,579,875 awarded for that fiscal year; activity R44 (SBIR); PI MEYN, MALCOLM A; recipient as written: AMALGENT THERAPEUTICS, INC., Greenville, NC. Development of an Opioid Sparing source ↗